Form 4: Solid Biosciences Director Clare Kahn Reports Acquisition of 1,100 Shares
SEC Filing
Director Clare Kahn of Solid Biosciences Inc. (SLDB) reported acquiring 1,100 shares of common stock at a price of $7.6742 per share on June 7, 2024.
Summary
- On June 7, 2024, Clare Kahn, a director of Solid Biosciences Inc. (SLDB), acquired 1,100 shares of the company's common stock.
- The purchase price was $7.6742 per share.
- Following the transaction, Ms. Kahn directly owns 1,100 shares of Solid Biosciences Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction by a company director. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track confidence levels and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transaction provides shareholders with insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Clare Kahn acquired 1,100 shares of Solid Biosciences Inc. common stock. |
| 06/11/2024 | Date of Form 4 filing with the SEC. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.